title: [An experiment study of reversed pulmonary hypertension with inhaled nitric oxide on smoke inhalation injury].
abstract: We evaluated the effect and mechanisms of reversed pulmonary hypertension with inhaled nitric oxide (NO) on smoke inhalation injury in the dog model, 21 dogs were divided into 3 groups randomly. Following smoke inhalation, the control group (n = 8) inhaled O2 (FiO2, 0.45) and the treated group (n = 9) inhaled O2 and 0.0045% (45 ppm) NO. Hemodynamics was serially measured for 12 hours. In addition, 4 dogs without smoke inhalation were used to study the normal lung histomophologic findings. The data were analyzed by ANOVA. After inhalation of NO, the mean pulmonary artery pressure (mPAP), pulmonary minute vessels pressure (Pmv), and pulmonary vascular resistance (PVR) were decreased significantly (P < 0.05), while the mean aortic pressure (mAP) and total peripheral resistance (TRP) were not remarkably changed (P > 0.05). The levels of cyclic guanosine monophosphate (cGMP) were increased significantly (P < 0.01). Inhaled NO may reverse pulmonary hypertension with smoke inhalation injury in dogs. The mechanism of selective pulmonary circulation was increased cGMP level in smooth cells. Inhaled NO may be recommended for clinical application.
authors.affiliation: Department of Burns and Plastic Surgery, Bethune International Peace Hospital, Shijiazhuang.
authors.forename: S
authors.initials: S
authors.lastname: Qi
authors.forename: Z
authors.initials: Z
authors.lastname: Yang
authors.forename: B
authors.initials: B
authors.lastname: He
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism; D004285:Dogs; D006439:Hemodynamics; D006975:Hypertension, Portal / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D009569:Nitric Oxide / Q000008:administration & dosage / Q000494:pharmacology*; D011897:Random Allocation; D015208:Smoke Inhalation Injury / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D009569:Nitric Oxide; D006152:Cyclic GMP